K. Jéhannin-ligier, E. Dantony, N. Bossard, F. Molinié, G. Defossez et al., Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2017, 2017.

. , Les cancers en France, Les Données, INCa, édition, 2015.

, Cancer Stat Facts: Melanoma of the skin. National Cancer Institute. Surveillance Epidemiology and End Results (SEER) Bethesda, MD

V. D. Criscione and M. A. Weinstock, Melanoma thickness trends in the United States, J Invest Dermatol, vol.130, pp.793-800, 1988.

P. G. Buettner, U. Leiter, T. K. Eigentler, and C. Garbe, Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society, Cancer, vol.103, pp.616-640, 2005.

A. Thuret, F. Binder-foucard, L. Coutard, A. Belot, A. Danzon et al., français des registres de cancer, Francim. Mélanome cutané infiltrant en France : évolution de l'incidence en fonction des facteurs histopronostiques sur la période, 1998.

F. El-ghissassi, R. Baan, K. Straif, Y. Grosse, B. Secretan et al., A review of human carcinogens-part D: radiation, Lancet Oncol, vol.10, pp.751-753, 2009.

, A review of human carcinogens. Part D : Radiation / IARC Monographs on the Evaluation of carcinogenic Risks to Humans, 2009.

S. Gandini, F. Sera, M. S. Cattaruzza, P. Pasquini, O. Picconi et al., Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure, Eur J Cancer, vol.41, pp.45-60, 2005.

S. Caini, S. Gandini, F. Sera, S. Raimondi, M. C. Fargnoli et al., Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant, Eur J Cancer, vol.45, issue.17, pp.3054-63, 2009.

M. Arnold, M. Kvaskoff, A. Thuret, P. Guénel, F. Bray et al., Cutaneous melanoma in France in 2015 attributable to solar ultraviolet radiation and the use of sunbeds, J Eur Acad Dermatol Venereol, 2018.

D. M. Parkin, D. Mesher, and P. Sasieni, Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010, Br J Cancer, vol.13, issue.2, pp.66-75, 2011.

C. M. Olsen, L. F. Wilson, A. C. Green, C. J. Bain, L. Fritschi et al., Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use, Aust N Z J Public Health, vol.39, issue.5, pp.471-477, 2015.

L. K. Dennis, M. J. Vanbeek, B. Freeman, L. E. Smith, B. J. Dawson et al., Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive metaanalysis, Ann Epidemiol. août, vol.18, issue.8, pp.614-641, 2008.

Y. Chang, J. H. Barrett, D. T. Bishop, B. K. Armstrong, V. Bataille et al., Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls, Int J Epidemiol, vol.38, issue.3, pp.814-844, 2009.

R. S. Stern, K. T. Nichols, and L. H. Väkevä, Malignant Melanoma in Patients Treated for Psoriasis with Methoxsalen (Psoralen) and Ultraviolet A Radiation (PUVA), N Engl J Med, vol.336, issue.15, pp.1041-1046, 1997.

H. E. Kanavy and M. R. Gerstenblith, Ultraviolet radiation and melanoma, Semin Cutan Med Surg. déc, vol.30, issue.4, pp.222-230, 2011.

D. Lazovich, R. I. Vogel, M. Berwick, M. A. Weinstock, K. E. Anderson et al., Indoor tanning and risk of melanoma: a case-control study in a highly exposed population, Cancer Epidemiol Biomarkers Prev, vol.19, pp.1557-68, 2010.

F. Grange, L. Mortier, A. Crine, C. Robert, B. Sassolas et al., Prevalence of sunbed use, and characteristics and knowledge of sunbed users: results from the French population-based Edifice Melanoma survey, J Eur Acad Dermatol Venereol, vol.29, issue.2, pp.23-30, 2015.

, International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review, Int J Cancer, vol.120, issue.5, pp.1116-1138, 2007.

S. Gandini, F. Sera, M. S. Cattaruzza, P. Pasquini, D. Abeni et al., Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi, Eur J Cancer, vol.41, pp.28-44, 2005.

C. M. Olsen, H. J. Carroll, and D. C. Whiteman, Estimating the attributable fraction for melanoma: a meta-analysis of pigmentary characteristics and freckling, Int J Cancer, vol.127, issue.10, pp.2430-2475, 2010.

S. Gandini, F. Sera, M. S. Cattaruzza, P. Pasquini, R. Zanetti et al., Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors, Eur J Cancer, vol.41, issue.14, pp.2040-59, 2005.

J. H. Silva, B. C. Sá, . De, A. Avila, . De et al., Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma-review article, Clinics, vol.66, issue.3, pp.493-502, 2011.

M. A. Tucker, Melanoma epidemiology, Hematol Oncol Clin North Am, vol.23, issue.3, pp.383-95, 2009.

J. T. Celebi, K. M. Ward, M. Wanner, D. Polsky, and A. W. Kopf, Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome, Clin Exp Dermatol, vol.30, pp.68-70, 2005.

J. A. Newton, V. Bataille, K. Griffiths, J. M. Squire, P. Sasieni et al., How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?, J Am Acad Dermatol, vol.29, issue.6, pp.989-96, 1993.

, Diagnosis and treatment of early melanoma, NIH Consensus conference, vol.268, pp.1314-1323, 1992.

R. J. Friedman, M. J. Farber, M. A. Warycha, N. Papathasis, M. K. Miller et al., The « dysplastic » nevus, Clin Dermatol, vol.27, issue.1, pp.103-118, 2009.

C. L. Egan, S. A. Oliveria, R. Elenitsas, J. Hanson, and A. C. Halpern, Cutaneous melanoma risk and phenotypic changes in large congenital nevi: A follow-up study of 46 patients, J Am Acad Dermatol, vol.39, issue.6, pp.923-955, 1998.

M. Vourc'h-jourdain, L. Martin, and S. Barbarot, Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review, J Am Acad Dermatol, vol.68, pp.493-498, 2013.

S. Krengel, A. Hauschild, and T. Schäfer, Melanoma risk in congenital melanocytic naevi: a systematic review, Br J Dermatol, vol.155, issue.1, pp.1-8, 2006.

F. V. Bittencourt, A. A. Marghoob, A. W. Kopf, K. L. Koenig, and R. S. Bart, Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis, Pediatrics, vol.106, issue.4, pp.736-777, 2000.

A. J. Swerdlow, J. English, and Z. Qiao, The risk of melanoma in patients with congenital nevi: A cohort study, J Am Acad Dermatol, vol.32, pp.595-604, 1995.

P. T. Bradford, D. M. Freedman, A. M. Goldstein, and M. A. Tucker, Increased risk of second primary cancers after a diagnosis of melanoma, Arch Dermatol, vol.146, pp.265-72, 2010.

E. L. Psaty, A. Scope, A. C. Halpern, and A. A. Marghoob, Defining the patient at high risk for melanoma, Int J Dermatol, vol.49, pp.362-76, 2010.

F. J. Moloney, P. Guitera, E. Coates, N. K. Haass, K. Ho et al., Detection of Primary Melanoma in Individuals at Extreme High Risk: A Prospective 5-Year Follow-up Study, JAMA Dermatol, vol.150, pp.819-846, 2014.

S. Negrier, P. Saiag, B. Guillot, O. Verola, M. F. Avril et al., Recommandations pour la pratique clinique : standards, options et recommandations 2005 pour la prise en charge des patients adultes atteints d'un mélanome cutané MO. Actualisation de la Conférence de Consensus de 1995 et des SOR de 1998, Ann Dermatol Venereol, vol.12, issue.132, pp.10-11, 2005.

C. R. Ferrone, B. Porat, L. Panageas, K. S. Berwick, M. Halpern et al., Clinicopathological features of and risk factors for multiple primary melanomas, JAMA Dermatol, vol.294, issue.13, pp.1647-54, 2005.

C. M. Olsen, H. J. Carroll, and D. C. Whiteman, Familial melanoma: a meta-analysis and estimates of attributable fraction, Cancer Epidemiol Biomarkers Prev, vol.19, pp.65-73, 2010.

K. Hemminki, H. Zhang, and K. Czene, Familial and attributable risks in cutaneous melanoma: effects of proband and age, J Invest Dermatol, vol.120, pp.217-240, 2003.

M. A. Tucker, M. C. Fraser, A. M. Goldstein, D. E. Elder, D. Guerry et al., Risk of melanoma and other cancers in melanoma-prone families, J Invest Dermatol, vol.100, pp.350-355, 1993.

A. M. Goldstein, M. Chan, M. Harland, N. K. Hayward, F. Demenais et al., Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents, J Med Genet, vol.44, pp.99-106, 2007.

L. Zuo, J. Weger, Q. Yang, A. M. Goldstein, M. A. Tucker et al., Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma, Nat Genet, vol.12, pp.97-106, 1996.

F. G. Haluska and F. S. Hodi, Molecular genetics of familial cutaneous melanoma, J Clin Oncol, vol.16, pp.670-82, 1998.

J. A. Curtin, J. Fridlyand, T. Kageshita, H. N. Patel, K. J. Busam et al., Distinct sets of genetic alterations in melanoma, N Engl J Med, vol.353, issue.20, pp.2135-2182, 2005.

E. Maubec, V. Chaudru, H. Mohamdi, C. Blondel, P. Margaritte-jeannin et al., Familial melanoma: Clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family, J Am Acad Dermatol, vol.67, issue.6, pp.1257-1264, 2012.

R. M. Fusaro and H. T. Lynch, The FAMMM syndrome: epidemiology and surveillance strategies, Cancer Invest, vol.18, issue.7, pp.670-80, 2000.

T. Wiesner, A. C. Obenauf, R. Murali, I. Fried, K. G. Griewank et al., Germline mutations in BAP1 predispose to melanocytic tumors, Nat Genet, vol.43, pp.1018-1039, 2011.

M. Carbone, H. Yang, H. I. Pass, T. Krausz, J. R. Testa et al., BAP1 and cancer, Nat Rev Cancer, vol.13, pp.153-162, 2013.

C. Njauw, K. I. Piris, A. Gabree, M. Taylor, M. Lane et al., Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and CutaneousOcular Melanoma Families, Plos one, vol.7, p.35295, 2012.

M. Avril, P. Bahadoran, O. Cabaret, O. Caron, A. De-la-fouchardière et al., Recommandations pour le diagnostic de prédisposition génétique au mélanome cutané et pour la prise en charge des personnes à risque, Ann dermatol vénéréol, vol.142, pp.26-36, 2015.

C. Bertolotto, F. Lesueur, S. Giuliano, T. Strub, . Lichy-m-de et al., A SUMOylationdefective MITF germline mutation predisposes to melanoma and renal carcinoma, Nature, vol.480, issue.7375, pp.94-102, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01791271

S. Yokoyama, S. L. Woods, G. M. Boyle, L. G. Aoude, S. Macgregor et al., A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma, Nature, vol.480, issue.7375, pp.99-103, 2011.

T. Debniak, R. J. Scott, B. Górski, C. Cybulski, T. Van-de-wetering et al., Common variants of DNA repair genes and malignant melanoma, Eur J Cancer, vol.44, pp.110-114, 2008.

K. Paszkowska-szczur, R. J. Scott, P. Serrano-fernandez, A. Mirecka, P. Gapska et al., Xeroderma pigmentosum genes and melanoma risk, Int J Cancer, vol.133, issue.5, pp.1094-100, 2013.

C. M. Vajdic, M. T. Van-leeuwen, A. C. Webster, M. Mccredie, J. H. Stewart et al., Cutaneous melanoma is related to immune suppression in kidney transplant recipients, Cancer Epidemiol Biomarkers Prev, vol.18, pp.2297-303, 2009.

L. Thomas, P. Tranchand, F. Berard, T. Secchi, C. Colin et al., Semiological value of ABCDE criteria in the diagnosis of cutaneous pigmented tumors, Dermatology (Basel), vol.197, issue.1, pp.11-18, 1998.

N. R. Abbasi, H. M. Shaw, D. S. Rigel, R. J. Friedman, W. H. Mccarthy et al., Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria, JAMA Dermatol, vol.292, issue.22, pp.2771-2777, 2004.

M. F. Healsmith, J. F. Bourke, J. E. Osborne, and R. A. Graham-brown, An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma, Br J Dermatol, vol.130, pp.48-50, 1994.

J. P. Banky, J. W. Kelly, D. R. English, J. M. Yeatman, and J. P. Dowling, Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma, Arch Dermatol, vol.141, pp.998-1006, 2005.

H. Kittler, H. Pehamberger, K. Wolff, and M. Binder, Diagnostic accuracy of dermoscopy, Lancet Oncol, vol.3, pp.159-65, 2002.

M. E. Vestergaard, P. Macaskill, P. E. Holt, and S. W. Menzies, Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting, Br J Dermatol, vol.159, issue.3, pp.669-76, 2008.

M. L. Bafounta, A. Beauchet, P. Aegerter, and P. Saiag, Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests, Arch Dermatol, vol.137, pp.1343-50, 2001.

P. Carli, D. Giorgi, V. Crocetti, E. Mannone, F. Massi et al., Improvement of malignant/benign ratio in excised melanocytic lesions in the « dermoscopy era »: a retrospective study 1997-2001, Br J Dermatol, vol.150, pp.687-92, 2004.

L. Thomas and P. S. Dermoscopy, Digital Dermoscopy and Other Diagnostic Tools in the Early Detection of Melanoma and Follow-up of High-risk Skin Cancer Patients, 2017.

G. Argenziano, H. P. Soyer, S. Chimenti, R. Talamini, R. Corona et al., Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet, J Am Acad Dermatol, vol.48, pp.679-93, 2003.

R. P. Braun, H. Rabinovitz, M. Oliviero, A. W. Kopf, J. H. Saurat et al., Dermatoscopy of pigmented lesions, Ann Dermatol Venereol, vol.129, pp.187-202, 2002.

R. P. Braun and L. Thomas, Atlas de dermoscopie, p.204, 2007.

A. A. Marghoob, R. P. Braun, and A. W. Kopf, Atlas of dermatoscopy. London: Taylor et Francis, 2004.

R. P. Braun, H. S. Rabinovitz, M. Oliviero, A. W. Kopf, and J. H. Saurat, Pattern analysis: a two-step procedure for the dermoscopic diagnosis of melanoma, Clin Dermatol, vol.20, issue.3, pp.236-245, 2002.

W. Stolz, U. Semmelmayer, K. Johow, and W. H. Burgdorf, Principles of dermatoscopy of pigmented skin lesions, Semin Cutan Med Surg, vol.22, issue.1, pp.9-20, 2003.

M. Binder, H. Kittler, A. Steiner, M. Dawid, H. Pehamberger et al., Reevaluation of the ABCD rule for epiluminescence microscopy, J Am Acad Dermatol, vol.40, pp.171-177, 1999.

A. Blum, G. Rassner, and C. Garbe, Modified ABC-point list of dermoscopy: A simplified and highly accurate dermoscopic algorithm for the diagnosis of cutaneous melanocytic lesions, J Am Acad Dermatol, vol.48, pp.672-680, 2003.

R. H. Johr, Dermoscopy: alternative melanocytic algorithms-the ABCD rule of dermatoscopy, Menzies scoring method, and 7-point checklist, Clin Dermatol, vol.20, issue.3, pp.240-247, 2002.

G. Argenziano, G. Fabbrocini, P. Carli, D. Giorgi, V. Sammarco et al., Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis, Arch Dermatol, vol.134, pp.1563-70, 1998.

H. Pehamberger, A. Steiner, and K. Wolff, In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions, J Am Acad Dermatol, vol.17, pp.571-83, 1987.

J. S. Henning, S. W. Dusza, S. Q. Wang, A. A. Marghoob, H. S. Rabinovitz et al., The CASH (color, architecture, symmetry, and homogeneity) algorithm for dermoscopy, J Am Acad Dermatol, vol.56, pp.45-52, 2007.

R. Schiffner, J. Schiffner-rohe, T. Vogt, M. Landthaler, U. Wlotzke et al., Improvement of early recognition of lentigo maligna using dermatoscopy, J Am Acad Dermatol, vol.42, pp.25-32, 2000.

T. Saida, S. Oguchi, and Y. Ishihara, In vivo observation of magnified features of pigmented lesions on volar skin using video macroscope. Usefulness of epiluminescence techniques in clinical diagnosis, Arch Dermatol, vol.131, pp.298-304, 1995.

D. Rosario, F. Farahi, J. M. Drendel, J. Buntinx-krieg, T. Caravaglio et al., Performance of a computer-aided digital dermoscopic image analyzer for melanoma detection in 1,076 pigmented skin lesion biopsies, J Am Acad Dermatol, vol.78, pp.927-934, 2018.

J. Malvehy and S. Puig, Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-step method, Clin Dermatol, vol.20, pp.297-304, 2002.

R. P. Braun, E. Lemonnier, J. Guillod, A. Skaria, D. Salomon et al., Two types of pattern modification detected on the follow-up of benign melanocytic skin lesions by digitized epiluminescence microscopy, Melanoma Res, vol.8, issue.5, pp.431-438, 1998.

W. Stolz, R. Schiffner, L. Pillet, T. Vogt, H. Harms et al., Improvement of monitoring of melanocytic skin lesions with the use of a computerized acquisition and surveillance unit with a skin surface microscopic television camera, J Am Acad Dermatol, vol.35, issue.2, pp.202-209, 1996.

S. Puig, G. Argenziano, I. Zalaudek, G. Ferrara, J. Palou et al., Melanomas that failed dermoscopic detection: a combined clinicodermoscopic approach for not missing melanoma, Dermatol Surg, vol.33, pp.1262-73

P. Tschandl, L. Hofmann, C. Fink, H. Kittler, and H. A. Haenssle, Melanomas vs. nevi in high-risk patients under long-term monitoring with digital dermatoscopy: do melanomas and nevi already differ at baseline?, J Eur Acad Dermatol Venereol, vol.31, pp.972-979, 2017.

H. Skvara, L. Teban, M. Fiebiger, M. Binder, and H. Kittler, Limitations of dermoscopy in the recognition of melanoma, Arch Dermatol, vol.141, pp.155-60, 2005.

H. A. Haenssle, U. Krueger, C. Vente, K. Thoms, H. P. Bertsch et al., Results from an observational trial: digital epiluminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma, J Invest Dermatol, vol.126, pp.980-985, 2006.

J. K. Robinson and B. J. Nickoloff, Digital epiluminescence microscopy monitoring of high-risk patients, Arch Dermatol, vol.140, pp.49-56, 2004.

S. W. Menzies, A. Gutenev, M. Avramidis, A. Batrac, and W. H. Mccarthy, Short-term of atypical or changing melanocytic lesions, Arch Dermatol, vol.137, pp.1583-1592, 2001.

H. Kittler, P. Guitera, E. Riedl, M. Avramidis, L. Teban et al., Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging, Arch Dermatol, vol.142, pp.1113-1122, 2006.

D. Altamura, M. Avramidis, and S. W. Menzies, Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma, Arch Dermatol, vol.144, pp.502-508, 2008.

G. Salerni, C. Carrera, L. Lovatto, R. M. Martí-laborda, G. Isern et al., Characterization of 1152 lesions excised over 10 years using total-body photography and digital dermatoscopy in the surveillance of patients at high risk for melanoma, J Am Acad Dermatol, vol.67, issue.5, pp.836-881, 2012.

S. R. Fuller, G. M. Bowen, B. Tanner, S. R. Florell, and D. Grossman, Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma, Dermatol Surg, vol.33, pp.1198-206, 2007.

G. Salerni, T. Terán, S. Puig, J. Malvehy, I. Zalaudek et al., Meta-analysis of digital dermoscopy follow-up of melanocytic skin lesions: a study on behalf of the International Dermoscopy Society, J Eur Acad Dermatol Venereol, vol.27, pp.805-819, 2013.

J. Berk-krauss, D. Polsky, and J. A. Stein, Mole Mapping for Management of Pigmented Skin Lesions, Dermatol Clin, vol.35, issue.4, pp.439-484, 2017.

G. Salerni, L. Lovatto, C. Carrera, S. Puig, and J. Malvehy, Melanomas detected in a follow-up program compared with melanomas referred to a melanoma unit, Arch Dermatol, vol.147, pp.549-55, 2011.

H. A. Haenssle, B. Korpas, C. Hansen-hagge, T. Buhl, K. M. Kaune et al., Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors, Arch Dermatol, vol.146, pp.257-64, 2010.

C. Rinner, P. Tschandl, C. Sinz, and H. Kittler, Long-term evaluation of the efficacy of digital dermatoscopy monitoring at a tertiary referral center, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, vol.15, pp.517-539, 2017.

H. Autorité-de-santé, Dermatoscopie pour surveillance cutanée : HAS, 2007.

M. Rotaru, A. Nati, I. Avr?moiu, F. Grosu, D. M?l?escu et al., digital dermoscopic follow-up of 1544 melanocytic nevi, Rom J Morphol Embryol, vol.56, issue.4, pp.1467-1472, 2015.

R. Schiffner, J. Schiffner-rohe, M. Landthaler, and W. Stolz, Long-term dermoscopic follow-up of melanocytic naevi: clinical outcome and patient compliance, Br J Dermatol, vol.149, issue.1, pp.79-86, 2003.

H. Kittler, M. Seltenheim, M. Dawid, H. Pehamberger, K. Wolff et al., Frequency and characteristics of enlarging common melanocytic nevi, Arch Dermatol, vol.136, pp.316-336, 2000.

C. Hansen, D. Wilkinson, M. Hansen, and G. Argenziano, How good are skin cancer clinics at melanoma detection? Number needed to treat variability across a national clinic group in Australia, J Am Acad Dermatol, vol.61, issue.4, pp.599-604, 2009.

E. Moscarella, R. Pampena, A. Kyrgidis, I. Tion, C. Longo et al., Digital dermoscopy monitoring in patients with multiple nevi: How many lesions should we monitor per patient?, J Am Acad Dermatol, vol.73, issue.1, pp.168-70, 2015.

H. Kittler, H. Pehamberger, K. Wolff, and M. Binder, Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi, J Am Acad Dermatol, vol.43, issue.3, pp.467-76, 2000.

J. Bauer, A. Blum, U. Strohhäcker, and C. Garbe, Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy, Br J Dermatol, vol.152, pp.87-92, 2005.

P. Carli, G. Ghigliotti, M. Gnone, A. Chiarugi, E. Crocetti et al., Baseline factors influencing decisions on digital follow-up of melanocytic lesions in daily practice: an Italian multicenter survey, J Am Acad Dermatol, vol.55, issue.2, pp.256-62, 2006.

G. Argenziano, I. Mordente, G. Ferrara, A. Sgambato, P. Annese et al., Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols, Br J Dermatol, vol.159, issue.2, pp.331-337, 2008.

L. Kofler, M. Egger, and H. Kofler, Sequential digital dermatoscopic imaging. How much time is required per patient?, Hautarzt, vol.65, pp.450-453, 2014.

E. Moscarella, I. Tion, I. Zalaudek, A. Lallas, A. Kyrgidis et al., Both short-term and long-term dermoscopy monitoring is useful in detecting melanoma in patients with multiple atypical nevi, J Eur Acad Dermatol Venereol, vol.31, pp.247-51, 2017.

S. W. Menzies and I. Zalaudek, Why perform dermoscopy? The evidence for its role in the routine management of pigmented skin lesions, Arch Dermatol, vol.142, pp.1211-1213, 2006.

V. Terushkin, S. W. Dusza, A. Scope, G. Argenziano, P. Bahadoran et al., Changes observed in slow-growing melanomas during long-term dermoscopic monitoring, Br J Dermatol, vol.166, pp.1213-1233, 2012.

G. Argenziano, I. Zalaudek, and G. Ferrara, Fast-growing and slow-growing melanomas, Arch Dermatol, vol.143, pp.802-806, 2007.

G. Argenziano, H. Kittler, G. Ferrara, P. Rubegni, J. Malvehy et al., Slow-growing melanoma: a dermoscopy follow-up study, Br J Dermatol, vol.162, issue.2, pp.267-73, 2009.

J. W. Kelly, J. M. Yeatman, C. Regalia, G. Mason, and A. P. Henham, A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance, Med J Aust, vol.167, issue.4, pp.191-195, 1997.

A. G. Goodson, S. R. Florell, M. Hyde, G. M. Bowen, and D. Grossman, Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma, Dermatol Surg, vol.36, pp.1087-98, 2010.

G. Salerni, C. Carrera, L. Lovatto, J. A. Puig-butille, C. Badenas et al., Benefits of total body photography and digital dermatoscopy (« two-step method of digital follow-up ») in the early diagnosis of melanoma in patients at high risk for melanoma, J Am Acad Dermatol, vol.67, issue.1, pp.17-27, 2012.

I. Tromme, L. Sacré, F. Hammouch, C. Legrand, L. Marot et al., Availability of digital dermoscopy in daily practice dramatically reduces the number of excised melanocytic lesions: results from an observational study, Br J Dermatol, vol.167, issue.4, pp.778-86, 2012.

J. Bauer, B. Leinweber, G. Metzler, A. Blum, R. Hofmann-wellenhof et al., Correlation with digital dermoscopic images can help dermatopathologists to diagnose equivocal skin tumours, Br J Dermatol, vol.155, issue.3, pp.546-51, 2006.

G. Salerni, T. Terán, C. Alonso, and R. Fernández-bussy, The role of dermoscopy and digital dermoscopy follow-up in the clinical diagnosis of melanoma: clinical and dermoscopic features of 99 consecutive primary melanomas, Dermatol Pract Concept, vol.4, issue.4, pp.39-46, 2014.

H. Kittler and M. Binder, Risks and benefits of sequential imaging of melanocytic skin lesions in patients with multiple atypical nevi, Arch Dermatol, vol.137, pp.1590-1595, 2001.

H. Kittler and M. Binder, Follow-up of melanocytic skin lesions with digital dermoscopy: risks and benefits, Arch Dermatol, vol.138, p.1379, 2002.

G. A. Gadens, Lack of compliance: a challenge for digital dermoscopy follow-up, Anais Brasileiros de Dermatologia, vol.89, issue.2, pp.242-246, 2014.

, Caisse Nationale de l'Assurance Maladie. Classification Commune des Actes Médicaux

J. Malvehy, S. Puig, G. Argenziano, A. A. Marghoob, and H. P. Soyer, International Dermoscopy Society Board members. Dermoscopy report: proposal for standardization. Results of a consensus meeting of the International Dermoscopy Society, J Am Acad Dermatol, vol.57, issue.1, pp.84-95, 2007.